These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29247685)

  • 21. Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles.
    Ishihara T; Takeda M; Sakamoto H; Kimoto A; Kobayashi C; Takasaki N; Yuki K; Tanaka K; Takenaga M; Igarashi R; Maeda T; Yamakawa N; Okamoto Y; Otsuka M; Ishida T; Kiwada H; Mizushima Y; Mizushima T
    Pharm Res; 2009 Oct; 26(10):2270-9. PubMed ID: 19633820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes.
    Koide H; Asai T; Hatanaka K; Akai S; Ishii T; Kenjo E; Ishida T; Kiwada H; Tsukada H; Oku N
    Int J Pharm; 2010 Jun; 392(1-2):218-23. PubMed ID: 20227473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Light induced cytosolic drug delivery from liposomes with gold nanoparticles.
    Lajunen T; Viitala L; Kontturi LS; Laaksonen T; Liang H; Vuorimaa-Laukkanen E; Viitala T; Le Guével X; Yliperttula M; Murtomäki L; Urtti A
    J Control Release; 2015 Apr; 203():85-98. PubMed ID: 25701610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated injections of PEGylated liposomal topotecan induces accelerated blood clearance phenomenon in rats.
    Ma Y; Yang Q; Wang L; Zhou X; Zhao Y; Deng Y
    Eur J Pharm Sci; 2012 Apr; 45(5):539-45. PubMed ID: 22155543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of stability of PEGylated micelles on the accelerated blood clearance phenomenon.
    Su Y; Liu M; Xiong Y; Ding J; Liu X; Song Y; Deng Y
    Drug Deliv Transl Res; 2019 Feb; 9(1):66-75. PubMed ID: 30378014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro stability and scintigraphic imaging for trafficking and tumor targeting of a directly and a novel ⁹⁹mTc(I)(CO)₃ labeled liposome.
    Fragogeorgi EA; Savina IN; Tsotakos T; Efthimiadou E; Xanthopoulos S; Palamaris L; Psimadas D; Bouziotis P; Kordas G; Mikhalovsky S; Alavijeh M; Loudos G
    Int J Pharm; 2014 Apr; 465(1-2):333-46. PubMed ID: 24583207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of liposomes on rheological and syringeability properties of hyaluronic acid hydrogels intended for local injection of drugs.
    El Kechai N; Bochot A; Huang N; Nguyen Y; Ferrary E; Agnely F
    Int J Pharm; 2015 Jun; 487(1-2):187-96. PubMed ID: 25882015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent advances in the study of accelerated blood clearance phenomenon of PEGylated liposomes].
    Xu H; Wang KQ; Huang WW; Deng YH; Chen DW
    Yao Xue Xue Bao; 2010 Jun; 45(6):677-83. PubMed ID: 20939173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated blood clearance of pegylated liposomal topotecan: influence of polyethylene glycol grafting density and animal species.
    Li C; Cao J; Wang Y; Zhao X; Deng C; Wei N; Yang J; Cui J
    J Pharm Sci; 2012 Oct; 101(10):3864-76. PubMed ID: 22777607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
    Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
    J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.
    Abu Lila AS; Kiwada H; Ishida T
    J Control Release; 2013 Nov; 172(1):38-47. PubMed ID: 23933235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Particle size-dependent triggering of accelerated blood clearance phenomenon.
    Koide H; Asai T; Hatanaka K; Urakami T; Ishii T; Kenjo E; Nishihara M; Yokoyama M; Ishida T; Kiwada H; Oku N
    Int J Pharm; 2008 Oct; 362(1-2):197-200. PubMed ID: 18586076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats.
    Ishida T; Kashima S; Kiwada H
    J Control Release; 2008 Mar; 126(2):162-5. PubMed ID: 18160170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An efficient dual-loaded multifunctional nanocarrier for combined photothermal and photodynamic therapy based on copper sulfide and chlorin e6.
    Tan X; Pang X; Lei M; Ma M; Guo F; Wang J; Yu M; Tan F; Li N
    Int J Pharm; 2016 Apr; 503(1-2):220-8. PubMed ID: 26988376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon.
    Shimizu T; Ishida T; Kiwada H
    Immunobiology; 2013 May; 218(5):725-32. PubMed ID: 22995937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The accelerated blood clearance phenomenon of PEGylated nanoemulsion upon cross administration with nanoemulsions modified with polyglycerin.
    Su Y; Wang L; Liang K; Liu M; Liu X; Song Y; Deng Y
    Asian J Pharm Sci; 2018 Jan; 13(1):44-53. PubMed ID: 32104377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan.
    Li C; Zhao X; Wang Y; Yang H; Li H; Li H; Tian W; Yang J; Cui J
    Int J Pharm; 2013 Feb; 443(1-2):17-25. PubMed ID: 23318366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of poly(ε-caprolactone) chain lengths of poly(ε-caprolactone)-co-d-α-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells.
    Suksiriworapong J; Phoca K; Ngamsom S; Sripha K; Moongkarndi P; Junyaprasert VB
    Eur J Pharm Biopharm; 2016 Apr; 101():15-24. PubMed ID: 26802701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Baicalin-loaded PEGylated cationic solid lipid nanoparticles modified by OX26 antibody on regulating the levels of baicalin and amino acids during cerebral ischemia-reperfusion in rats.
    Liu Z; Zhang L; He Q; Liu X; Okeke CI; Tong L; Guo L; Yang H; Zhang Q; Zhao H; Gu X
    Int J Pharm; 2015 Jul; 489(1-2):131-8. PubMed ID: 25895718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas.
    Amin M; Badiee A; Jaafari MR
    Int J Pharm; 2013 Dec; 458(2):324-33. PubMed ID: 24148663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.